Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M65,229Revenue (TTM) $M15,982Net Margin (%)2.0Altman Z-Score1.9
Enterprise Value $M85,569EPS (TTM) $0.4Operating Margin %14.0Piotroski F-Score4
P/E(ttm)605Beneish M-Score-1.9Pre-tax Margin (%)7.3Higher ROA y-yN
Price/Book3.110-y EBITDA Growth Rate %4.8Quick Ratio0.7Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %7.6Current Ratio1.0Lower Leverage y-yY
Price/Free Cash Flow33.1y-y EBITDA Growth Rate %26.1ROA % (ttm)0.6Higher Current Ratio y-yN
Dividend Yield %1.3PEG77.7ROE % (ttm)0.8Less Shares Outstanding y-yN
Payout Ratio %500Shares Outstanding M269ROIC % (ttm)1.6Gross Margin Increase y-yN

Gurus Latest Trades with BDX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

BDX is held by these investors:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History

BDX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Borzi James WEVP & Chief Supply Chain Offcr 2018-11-30Sell5,887$252.37-6.44view
Polen Thomas E JrExecutive Vice President 2018-11-19Sell5,243$243.86-3.18view
Bodner Charles RSVP Corp Fin Chief Acct Office 2018-11-16Sell2,080$245.83-3.95view
Mas Ribo AlbertoEVP and Pres, Life Sciences 2018-11-14Sell4,530$237.01-0.38view
FORLENZA VINCENT AChairman, CEO and President 2018-11-14Sell13,498$235.780.14view
FORLENZA VINCENT AChairman, CEO and President 2018-11-13Sell16,866$237.61-0.63view
Lim James CExecutive Vice President 2018-11-08Sell5,189$242.36-2.58view
RING TIMOTHY MDirector 2018-11-07Sell42,000$237.07-0.4view
Conroy AlexandreExecutive Vice President 2018-05-21Sell20,128$228.743.22view
Shabshab NabilExecutive Vice President 2018-05-11Sell10,209$226.14.43view

Press Releases about BDX :

Quarterly/Annual Reports about BDX:

News about BDX:

Articles On GuruFocus.com
BD Announces Preliminary Results For 2019 First Fiscal Quarter; Reaffirms Fiscal 2019 Guidance Jan 17 2019 
BD Announces Webcast of Annual Meeting of Shareholders Jan 15 2019 
BD Announces Live Webcast Of First Fiscal Quarter Earnings Conference Call Jan 08 2019 
52-Week Company Lows Jan 07 2019 
BD to Present at Investor Healthcare Conferences Dec 21 2018 
BD Completes Molecular Portfolio for GI Infection With New Viral Panel Dec 20 2018 
BD Announces Completion Of Enterprise Level Cybersecurity Assessment From UL Dec 11 2018 
BD Expands Integrated Medication Management to Help Tackle Hospital Drug Diversion Nov 29 2018 
Jeff Auxier Sells Mastercard, PepsiCo, Microsoft Nov 27 2018 
New Diagnostic Test Helps Hospitals More Quickly Identify and Treat Emerging Antibiotic-Resistant Ba Nov 13 2018 

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat